Anti-Microbial Savior BioteQ Co., Ltd. (6864) Stock Statistics & Valuation Metrics
Total Valuation
Anti-Microbial Savior BioteQ Co., Ltd. has a market cap or net worth of TWD 1.29B. The enterprise value is ―.
- Market Cap
- TWD 1.29B
- Enterprise Value
- ―
Share Statistics
Anti-Microbial Savior BioteQ Co., Ltd. has 37,874,750 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 37,874,750
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Anti-Microbial Savior BioteQ Co., Ltd.’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -18.76%.
- Return on Equity (ROE)
- -0.18
- Return on Assets (ROA)
- -0.18
- Return on Invested Capital (ROIC)
- -18.76%
- Return on Capital Employed (ROCE)
- -0.19
- Revenue Per Employee
- 47.07K
- Profits Per Employee
- -6.24M
- Employee Count
- 15
- Asset Turnover
- 0.00
- Inventory Turnover
- 6.98
Valuation Ratios
The current PE Ratio of Anti-Microbial Savior BioteQ Co., Ltd. is -14.77. Anti-Microbial Savior BioteQ Co., Ltd.’s PEG ratio is -0.15.
- PE Ratio
- -14.77
- PS Ratio
- 1138.05
- PB Ratio
- 3.03
- Price to FCF
- -14.41
- Price to Operating Cash Flow
- -17.75
- PEG Ratio
- -0.15
Income Statement
In the last 12 months, Anti-Microbial Savior BioteQ Co., Ltd. had revenue of 706.00K and earned -93.60M in profits. Earnings per share was -2.88.
- Revenue
- 706.00K
- Gross Profit
- -10.81M
- Operating Income
- -95.98M
- Pretax Income
- -93.60M
- Net Income
- -93.60M
- EBITDA
- -84.85M
- Earnings Per Share (EPS)
- -2.88
Cash Flow
In the last 12 months, operating cash flow was -80.47M and capital expenditures -18.85M, giving a free cash flow of -99.33M billion.
- Operating Cash Flow
- -80.47M
- Free Cash Flow
- -99.33M
- Free Cash Flow per Share
- -2.63
Dividends & Yields
Anti-Microbial Savior BioteQ Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -6.99%
- Earnings Yield
- -6.29%
Stock Price Statistics
- Beta
- 0.55
- 52-Week Price Change
- -58.01%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 28.78
- Average Volume (3m)
- 62.09K
Financial Position
Anti-Microbial Savior BioteQ Co., Ltd. as a current ratio of 47.84, with Debt / Equity ratio of 0.24%
- Current Ratio
- 47.84
- Quick Ratio
- 47.67
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 5.48
- Interest Coverage Ratio
- -4570.71
Taxes
In the past 12 months, Anti-Microbial Savior BioteQ Co., Ltd. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Anti-Microbial Savior BioteQ Co., Ltd. EV to EBITDA ratio is -12.97, with an EV/FCF ratio of -10.75.
- EV to Sales
- 848.70
- EV to EBITDA
- -12.97
- EV to Free Cash Flow
- -10.75
- EV to Operating Cash Flow
- -13.27
Balance Sheet
Anti-Microbial Savior BioteQ Co., Ltd. has TWD 401.11M in cash and marketable securities with TWD 48.47M in debt, giving a net cash position of TWD 352.64M billion.
- Cash & Marketable Securities
- TWD 401.11M
- Total Debt
- TWD 48.47M
- Net Cash
- TWD 352.64M
- Net Cash Per Share
- TWD 9.31
- Tangible Book Value Per Share
- TWD 12.45
Margins
Gross margin is -893.88%, with operating margin of -7407.95%, and net profit margin of -7082.35%.
- Gross Margin
- -893.88%
- Operating Margin
- -7407.95%
- Pretax Margin
- -7082.35%
- Net Profit Margin
- -7082.35%
- EBITDA Margin
- -6541.41%
- EBIT Margin
- -7407.95%
Analyst Forecast
The average price target for Anti-Microbial Savior BioteQ Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 125.85%
- EPS Growth Forecast
- 6.15%
